Please see below some additional medical research funding opportunities with current deadlines. For the Coronavirus (COVID-19) specific research grant opportunities visit the COVID-19 Funding Opportunity page.
Science & SciLifeLab Prize for Young Scientists │ Deadline: July 15
The Science & SciLifeLab Prize for Young Scientists is an annual prize awarded to early-career scientists. The prize is presented in four categories:
- Cell and Molecular Biology
- Genomics, Proteomics and Systems Biology Approaches
- Ecology and Environment
- Molecular Medicine
Applicants are to submit a 1000-word essay that is judged by an independent editorial team organized by the journal Science. Essays are judged on the quality of research and the applicants’ ability to articulate how their work would contribute to the scientific field.
Eligibility: Eligible entrants must have been awarded their doctoral degree in 2018 or 2019. The winners from each category will compete for the Grand Prize.
Funding: The Grand Prize winner will receive 30,000 USD, be published in Science magazine, be invited to Sweden where you will receive your award, present your research and meet with leading scientists in your field. The three remaining category winners will receive 10,000 USD each and be published in Science online.
Questions? Email: SciLifeLabPrize@aaas.org
Deadline: July 15, 2020
Smith Family Awards Program for Excellence in Biomedical Research │ Deadline: August 18
The Smith Family Awards Program for Excellence in Biomedical Research purpose is to launch the careers of newly independent biomedical researchers with the ultimate goal of achieving medical breakthroughs. The Smith Family awards are made to investigators based at academic, medical or research institutions in Massachusetts, and at Brown and Yale.All fields of basic biomedical science, as well as physics, chemistry and engineering are accepted. Grantees’ research must address an important problem and have high potential for generating a medical breakthrough in the longer-term.Funding Available: $300,000 over three years (inclusive of 5 percent overhead).
- Applicants must be full-time faculty.
- Applicants must have received or expect to receive their first independent faculty appointment on or between October 1, 2018 through April 1, 2021.
- If an Applicant has been on medical or family leave, or if research was interrupted for other reasons, this period of absence does not count towards eligibility.
- Postdocs must have completed training by the funding start date of April 1, 2021.
US citizenship is not required
Current, Pending and Post Award Funding:
- Applicants are ineligible if, at the time of application, they have combined federal and non-federal funding totaling $500,000 or more in direct costs in either of the first two years (4/1/21 – 3/31/22 or 4/1/22 – 3/31/23) of the three-year Smith Award. This figure refers to external funding only.
- Applicants are ineligible if they were previously or are currently a Principal Investigator or Multiple PI (NIH), Co-PI (NSF), or equivalent on an R01, P01, Pioneer Award, New Innovator Award or similar large awards from other federal agencies or national foundations.
- Applicants who have pending R01s or other large applications to the NIH and other agencies are encouraged to apply.
Self-nomination: In 2020, unlike previous years, an institutional nomination for the Smith Family Awards is not required. There is no limit on the number of applicants from a given institution, so there will be no internal competition. Investigators may self-nominate.
Deadlines: Initial Proposal August 18, 2020 ǀ Full proposal: not specified
Foundation Contact: Lindsey Carver, Grants Officer,email@example.com
Internal contacts: For BUSM, BUSPH, and BUSDM investigators, the primary source of assistance in the pursuit of funding from private philanthropic organizations and the submission of funding requests to them is the BU Medical Campus Foundation Relations office. BU investigators should contact David Gillerman, Director at firstname.lastname@example.org – (617) 359-8089. If you are a BMC investigator and wish to apply for this opportunity, please contact Jennifer Fleming, Director of Foundation Relations and Government Grants at email@example.com.
Charles Hood Child Health Research Awards Program │ Deadline: September 16
The Charles H. Hood Foundation was incorporated in 1942 to improve the health and quality of life for children throughout New England. Today’s research projects encompass many disciplines that have contributed to discoveries in pediatric medicine while launching the careers of promising junior faculty. The intent of the Child Health Research Awards Program is to support newly independent faculty, provide the opportunity to demonstrate creativity, and assist in the transition to other sources of funding. Research projects must have direct relevance to child health.
Funding Period and Award Amount
- January 1, 2021 – December 31, 2022
- Up to five $165,000 awards at $82,500 per year (inclusive of 10% institutional overhead)
Applicant, Project and Geographic Eligibility
- PhD scientists within five years and physician scientists within seven years of employment following conclusion of training
- Research with direct relevance to child health
- Hypothesis-driven clinical, basic science, public health, health services research, and epidemiology projects
- Nonprofit academic, medical or research institutions in New England
- United States citizenship or permanent residency not required
- Complete eligibility requirements are detailed in the “Application Guidelines”
Please direct any questions to Charlene Mancusi, Program Officer at Charlene.Mancusi@CharlesHoodFoundation.org
Deadline: September 16, 2020
Pfizer's CTI │ Deadline: September 21
The Pfizer’s Centers for Therapeutic Innovation (CTI) is a unique joint drug discovery model focused on collaborating with leading academic medical centers to translate and transform concepts into breakthroughs that change patients’ lives.
CTI has four areas of focus:
- Opportunities related to DNA damage response and replicative stress in the context of nuclear or spatial organization.
- Novel strategies targeting the cause or treatment of repeat expansion diseases.
- Opportunities to target Cellular Senescence, including senolytic and senomomorphic approaches.
- Opportunities related to Tissue-Immune System Crosstalk in disease pathology.
- Funding for project-specific research
- Hands-on collaboration from dedicated Pfizer drug-development experts
- Access to scientific/technological expertise and infrastructure at Pfizer
- Potential for in-licensing by Pfizer, which would include milestone and royalty payments
- Publishing rights
Pre-Proposal Submission Process: Submission entails a non-confidential 2-3 page overview of the target, mechanism, evidence for disease linkage, and the proposed therapeutic drug. At a high level, the pre-proposal should suggest how the therapeutic hypothesis could be tested in the clinic. Please submit non-confidential pre-proposals to Technology Development by September 21, 2020. For further information about submitting a pre-proposal, please contact Nevena Dimova at firstname.lastname@example.org.
Internal Deadline: Monday, September 21, 2020